Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Star Matrix vs Autogenous Graft for Gingival Augmentation: Split-Mouth RCT

Harvard Medical School (HMS and HSDM) · NCT07440303

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 20–80 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
12
US sites recruiting
1
Study start
November 6, 2025
Record last updated
February 27, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This split-mouth randomized controlled clinical trial will test whether a ready-to-use collagen membrane (Star Matrix) can widen the protective band of gum tissue (keratinized gingiva) as effectively as the standard free gingival graft harvested from the palate.

Central question Can Star Matrix provide the same or better gain in keratinized tissue width-with less patient discomfort and chair-time-than an autogenous graft?

Primary objectives

Compare the 6-month increase in keratinized tissue width between Star Matrix and autogenous graft sites.

Assess patient-reported pain and morbidity associated with each treatment.

Secondary objectives

Measure operative time, early healing scores, esthetic outcomes, and (optional) histologic quality of the regenerated tissue.

Methods Twelve adults with ≤ 2 mm keratinized tissue on contralateral lower-jaw teeth will be enrolled. Each participant receives Star Matrix on one side and a conventional free gingival graft on the other. Follow-up visits at 2, 4, 8, 12 and 24 weeks include clinical measurements, standardized photographs, and a 7-day postoperative pain diary. An optional 2 mm punch biopsy at 6 months is analyzed microscopically.

Being studied: Starmatrix collagen membrane; Autogenous gingival graft

Conditions: Lack of Keratinized Gingiva; Mucogingival Deformity - Insufficient Keratinized Tissue

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Adults 20 - 80 years old who need gingival augmentation on both sides of the lower jaw.
  • Able and willing to sign the consent form, follow study instructions and return for all visits
  • Generally healthy (no significant illnesses or medicines that could interfere with healing).
  • Demonstrates good daily oral hygiene (low plaque levels at baseline).

Exclusion Criteria

  • Does not meet any of the inclusion points or is unlikely to follow the schedule
  • Previous gingival graft at the study site that failed
  • Needs a root-coverage (recession-repair) procedure instead of simple width augmentation
  • Active, untreated gum disease, cavities, infection, or chronic inflammation near the study teeth
  • Used cigarettes, e-cigarettes, or other nicotine products within 3 weeks
  • Insulin-dependent diabetes or hemoglobin A1c > 6.5 %
  • Cancer (other than minor skin cancers or in-situ cervical cancer) within the past 5 years
  • Currently pregnant or breastfeeding
  • Taking (or soon to begin) drugs that change bone turnover (e.g., bisphosphonates, steroids)
  • Diseases that disturb bone metabolism (except common osteoporosis)
  • Auto-immune disease or known allergy to porcine collagen or study materials
  • Active infection at the planned graft site
  • Current use of systemic blood thinners (anticoagulants or antiplatelet agents; e.g., warfarin, heparin/LMWH, DOACs such as apixaban/rivaroxaban/dabigatran/edoxaban, or P2Y12 inhibitors such as clopidogrel/prasugrel/ticagrelor)

Recruiting US locations

Study contacts (from the official record)

  • David Kim, DDS, DMSc · (617) 432-1434 · dkim@hsdm.harvard.edu
All healthy volunteers studies in Massachusetts →
Star Matrix vs Autogenous Graft for Gingival Augmentation:… (NCT07440303) | Bored Studies